Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab. Lee D-H, Waschbisch A, Lämmer AB, Doerfler A, Schwab S, Linker RA J Neuroinflammation. 2013 Oct 9; 10(1):123. Epub 2013 Oct 09. PMID: 24107235. Abstract CommentRecommendBookmarkWatch